AAPL vs MRK: Which Is the Better Buy?

Side-by-side comparison of Apple Inc. and Merck & Co., Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
Apple Inc. Β· Technology
$337.02
+9.9% upside to fair value
Med Conviction Grade B High Quality
VS
Merck & Co., Inc. Β· Healthcare
$147.17
-4.1% upside to fair value
Med Conviction Grade C
QuantHub Verdict
AAPL has more upside to fair value (+9.9%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric AAPL MRK
Current Price $337.02 $147.17
Fair Value Estimate $370.54 $141.07
Upside to Fair Value +9.9% -4.1%
Market Cap $4,949.9B $363.5B
Forward P/E β€” β€”
EV / EBITDA 29.6x 29.6x
Price / Sales 10.6x 5.5x
Price / FCF 36.2x 22.6x
Revenue Growth YoY +16.4% +5.1%
Gross Margin 48.7% 75.4%
Operating Margin 33.2% 16.7%
Return on Equity 137.2% 6.6%
Dividend Yield 0.31% 2.31%
FCF Yield 2.76% 4.42%
Analyst Consensus Buy Buy
Investment Thesis
AAPL β€” Apple Inc.
Apple Inc. is a global consumer-electronics and services platform whose hardware lineup (iPhone, Mac, iPad, wearables) and digital ecosystem (App Store, Apple Music, iCloud, Apple Pay, advertising) generated $31.78 of revenue per share and $9.30 of free cash flow per share on a trailing basis, with TTM gross margin of 48.7%, operating margin of 33.2%, net margin of 27.6%, and ROE of 137.2%. Busin…
MRK β€” Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
Accumulation Zones
Metric AAPL MRK
Zone Low $277.91 $105.80
Zone High $314.96 $119.91
In Buy Zone? No No
← AAPL Research    MRK Research β†’    All Research